New Survey Provides Dramatic Statistics Showing Employment and Financial Impact of Lupus

In a survey sponsored by Human Genome Sciences and GlaxoSmithKline, makers of a treatment for lupus, a majority of patients, supporters and doctors report that people with lupus change career plans because of lupus. More than half (63 percent) of respondents with lupus quit working or retired earlier than planned, about two-thirds (67 percent) reduced the number hours worked, and 51 percent of patients changed to a less strenuous job.

Full Story